Financial toxicity in gynecologic oncology-Reference-Cited by-同舟云学术

Financial toxicity in gynecologic oncology

Published:2019-07 Issue:1 Volume:154 Page:8-12
ISSN:0090-8258
Container-title:Gynecologic Oncology
language:en
Short-container-title:Gynecologic Oncology

Author:

Bouberhan Sara,Shea Meghan^ORCID,Kennedy Alice,Erlinger Adrienne,Stack-Dunnbier Hannah,Buss Mary K.,Moss Laureen,Nolan Kathleen,Awtrey Christopher,Dalrymple John L.,Garrett Leslie,Liu Fong W.,Hacker Michele R.,Esselen Katharine M.

Funder

Eleanor and Miles Shore 50th Anniversary Fellowship Program

Harvard Catalyst

Harvard Clinical and Translational Science Center

National Center for Advancing Translational Sciences

National Institutes of Health

Harvard University

Publisher

Elsevier BV

Subject

Obstetrics and Gynaecology,Oncology

Reference17 articles.

1. The development of a financial toxicity patient-reported outcome in cancer: The COST measure;de Souza;Cancer,2014

2. Measuring financial toxicity as a clinically relevant patient-reported outcome: The validation of the COmprehensive Score for financial Toxicity (COST);de Souza;Cancer,2017

3. Washington State cancer patients found to be at greater risk for bankruptcy than people without a cancer diagnosis;Ramsey;Health Aff (Millwood),2013

4. Financial insolvency as a risk factor for early mortality among patients with cancer;Ramsey;J. Clin. Oncol.,2016

5. Population-based assessment of cancer survivors' financial burden and quality of life: a prospective cohort study;Zafar;J Oncol Pract,2015

Cited by 92 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Implementation of a financial navigation program in gynecologic oncology;Gynecologic Oncology;2024-10

2. Screening for Financial Toxicity Among Patients With Cancer: A Systematic Review;Journal of the American College of Radiology;2024-09

3. Toward a Framework to Assess the Financial and Economic Burden of Cervical Cancer in Low- and Middle-Income Countries: A Systematic Review;JCO Global Oncology;2024-08

4. “Having cancer is very expensive”: A qualitative study of patients with ovarian cancer and PARP inhibitor treatment;Gynecologic Oncology;2024-07

5. Unmet financial needs among patients crowdfunding to support gynecologic cancer care;Gynecologic Oncology;2024-07